APLT Deadline: APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit
Portfolio Pulse from
Rosen Law Firm has announced a lead plaintiff deadline of February 18, 2025, for a securities fraud lawsuit against Applied Therapeutics, Inc. (NASDAQ: APLT). Investors who purchased APLT securities between January 3, 2024, and December 2, 2024, may be eligible for compensation.
February 11, 2025 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Therapeutics is facing a securities fraud lawsuit with a lead plaintiff deadline on February 18, 2025. Investors who purchased shares during the specified period may be eligible for compensation.
The announcement of a securities fraud lawsuit against Applied Therapeutics is likely to negatively impact its stock price in the short term. Legal issues can lead to investor uncertainty and potential financial liabilities, which may result in a decrease in stock value.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100